Anhui Huangshan Capsule Co Ltd

SHE:002817 China Drug Manufacturers - Specialty & Generic
Market Cap
$344.05 Million
CN¥2.52 Billion CNY
Market Cap Rank
#15050 Global
#4012 in China
Share Price
CN¥8.44
Change (1 day)
+1.44%
52-Week Range
CN¥5.90 - CN¥8.54
All Time High
CN¥62.96
About

Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. It offers hypromellose empty capsules, pullulan empty capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow caps… Read more

Anhui Huangshan Capsule Co Ltd (002817) - Total Liabilities

Latest total liabilities as of September 2025: CN¥156.93 Million CNY

Based on the latest financial reports, Anhui Huangshan Capsule Co Ltd (002817) has total liabilities worth CN¥156.93 Million CNY as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Anhui Huangshan Capsule Co Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Anhui Huangshan Capsule Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Anhui Huangshan Capsule Co Ltd Competitors by Total Liabilities

The table below lists competitors of Anhui Huangshan Capsule Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Zhejiang Int'L Group Co Ltd
SHE:000411
China CN¥11.95 Billion
Nevro Corp
NYSE:NVRO
USA $322.83 Million
BingEx Ltd
NASDAQ:FLX
USA $432.60 Million
Zhejiang Aishida Electric Co Ltd
SHE:002403
China CN¥3.18 Billion
Churchill Capital Corp IX
NASDAQ:CCIX
USA $10.24 Million
Fanli Digital Technology Co Ltd
SHG:600228
China CN¥161.42 Million
Linklogis Inc.
PINK:LNKLF
USA $1.03 Billion
Lihe Technology
SHE:300800
China CN¥449.77 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Anhui Huangshan Capsule Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.55 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.16 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Anhui Huangshan Capsule Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Anhui Huangshan Capsule Co Ltd (2011–2024)

The table below shows the annual total liabilities of Anhui Huangshan Capsule Co Ltd from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥168.77 Million -16.44%
2023-12-31 CN¥201.97 Million +10.08%
2022-12-31 CN¥183.48 Million -24.75%
2021-12-31 CN¥243.84 Million +61.85%
2020-12-31 CN¥150.66 Million +42.84%
2019-12-31 CN¥105.48 Million +26.40%
2018-12-31 CN¥83.45 Million +14.89%
2017-12-31 CN¥72.63 Million +6.17%
2016-12-31 CN¥68.41 Million -23.21%
2015-12-31 CN¥89.08 Million +25.08%
2014-12-31 CN¥71.22 Million -20.25%
2013-12-31 CN¥89.30 Million +34.37%
2012-12-31 CN¥66.46 Million +36.40%
2011-12-31 CN¥48.73 Million --